Author Biography: Li |
| Last Updated: December 6, 2007 |
|
Dr. Albert P. Li obtained his Ph.D. degree in Biomedical Sciences from the University of Tennessee, Oak Ridge Graduate School of Biomedical Sciences, with Dr. Abraham Hsie of Oak Ridge National Laboratories. He is currently Co-Founder, President and Chief Executive Officer of In Vitro ADMET Laboratories LLC (IVAL, Columbia, Maryland), Advanced Pharmaceutical Sciences Inc. (APSciences, Columbia, Maryland), and BRiVAL Inc. (Vancouver, British Columbia). Dr. Li's companies provide in vitro toxicity testing service (IVAL), in vitro drug metabolism service (BRiVAL), and in vitro cell-based products (APSciences). Dr. Li was previously President and CEO of Phase I Molecular Toxicology Inc. (Santa Fe, New Mexico), Chief Scientific Officer of In Vitro Technologies Inc. (Baltimore, Maryland), Director and Research Professor, Surgical Research Laboratories, St. Louis University Medical School (St. Louis, Missouri), Senior Research Fellow, Monsanto Company (St. Louis, Missouri), Cellular and Genetic Toxicology Group Leader, Lovelace Inhalation Research Institute (Albuquerque, New Mexico), and Research Scientist and Assistant Professor, Cancer Research and Treatment Center, University of New Mexico (Albuquerque, New Mexico).
Dr. Li is one of the pioneers in the development and applications of human-based in vitro experimental systems in the evaluation of human drug properties. He was instrumental in the now generally accepted approach of the use of in vitro human liver models in the evaluation of drug metabolism and drug-drug interactions. His latest contributions include the optimization of cryopreservation procedures for human hepatocytes and, most notably, the invention of the Integrated Discrete Multiple Organ Co-culture (IdMOC) system which models the whole animal/human, allowing the evaluation of multiple organ toxicity while allowing multiple organ interactions as occur in vivo. The IdMOC system has been allowed a US patent in 2007. Dr. Li has published over 150 peer-reviewed papers, edited 5 books and 5 journal issues, and authored three US patents. He serves as editor and editorial board members on various journals in toxicology and drug metabolism.
Albert P. Li, Ph.D.
Advanced Pharmaceutical Sciences Inc. and In Vitro ADMET Laboratories Inc.
9221 Rumsey Road Suite 8
Columbia, Maryland 21045
E-mail: lialbert@invitroadmet.com | 
|
